•Executive Summary o Market Overview •Market Landscape o Market ecosystem o Value chain analysis •Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 •Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition •Market Segmentation by Type o Market segments o Comparison by Type placement o Drugs - Market size and forecast 2019-2024 o Vaccines - Market size and forecast 2019-2024 o Market opportunity by Type •Customer landscape o Overview •Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography •Drivers, Challenges, and Trends o Market drivers o Volume driver - Demand led growth o Volume driver - Supply led growth o Volume driver - External factors o Volume driver - Demand shift in adjacent markets o Price driver - Inflation o Price driver - Shift from lower to higher-priced units o Market challenges o Market trends •Vendor Landscape o Overview o Landscape disruption •Vendor Analysis o Vendors covered o Market positioning of vendors o Amgen Inc. o Biocon Ltd. o Cipla Inc. o Dr. Reddy's Laboratories Ltd. o F. Hoffmann-La Roche Ltd. o Fresenius SE & Co. KGaA o GlaxoSmithKline Plc o Merck & Co. Inc. o Novartis AG o Pfizer Inc. •Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations •1.Key Finding 1 •2.Key Finding 2 •3.Key Finding 3 •4.Key Finding 5 •5.Key Finding 6 •6.Key Finding 7 •7.Key Finding 8 •8.Market in focus •9.Parent market •10.Market characteristics •11.Product / Service portfolio of key vendors included in the market definition •12.Market segments •13. •14.Global - Market size and forecast 2019 - 2024 ($ million) •15.Global market: Year-over-year growth 2019 - 2024 (%) •16.Five forces analysis 2019 & 2024 •17.Bargaining power of buyers •18.Bargaining power of suppliers •19.Threat of new entrants •20.Threat of substitutes •21.Threat of rivalry •22.Market condition - Five forces 2019 •23.Type placement - Market share 2019-2024 (%) •24.Comparison by Type placement •25.Drugs - Market size and forecast 2019-2024 ($ million) •26.Drugs - Year-over-year growth 2019-2024 (%) •27.Vaccines - Market size and forecast 2019-2024 ($ million) •28.Vaccines - Year-over-year growth 2019-2024 (%) •29. Market opportunity by Type •30.Customer landscape •31.Market share by geography 2019-2024 (%) •32.Geographic comparison •33.North America - Market size and forecast 2019-2024 ($ million) •34.North America - Year-over-year growth 2019-2024 (%) •35.Europe - Market size and forecast 2019-2024 ($ million) •36.Europe - Year-over-year growth 2019-2024 (%) •37.Asia - Market size and forecast 2019-2024 ($ million) •38.Asia - Year-over-year growth 2019-2024 (%) •39.ROW - Market size and forecast 2019-2024 ($ million) •40.ROW - Year-over-year growth 2019-2024 (%) •41.Key leading countries •42.Market opportunity by geography ($ million) •43.Impact of drivers and challenges •44.Vendor landscape •45.Landscape disruption •46.Industry risks •47.Vendors covered •48.Market positioning of vendors •49.Amgen Inc. - Overview •50.Amgen Inc. - Business segments •51.Amgen Inc. - Key offerings •52.Amgen Inc. - Key customers •53.Amgen Inc. - Segment focus •54.Biocon Ltd. - Overview •55.Biocon Ltd. - Business segments •56.Biocon Ltd. - Key offerings •57.Biocon Ltd. - Key customers •58.Biocon Ltd. - Segment focus •59.Cipla Inc. - Overview •60.Cipla Inc. - Business segments •61.Cipla Inc. - Key offerings •62.Cipla Inc. - Key customers •63.Cipla Inc. - Segment focus •64.Dr. Reddy's Laboratories Ltd. - Overview •65.Dr. Reddy's Laboratories Ltd. - Business segments •66.Dr. Reddy's Laboratories Ltd. - Key offerings •67.Dr. Reddy's Laboratories Ltd. - Key customers •68.Dr. Reddy's Laboratories Ltd. - Segment focus •69.F. Hoffmann-La Roche Ltd. - Overview •70.F. Hoffmann-La Roche Ltd. - Business segments •71.F. Hoffmann-La Roche Ltd. - Key offerings •72.F. Hoffmann-La Roche Ltd. - Key customers •73.F. Hoffmann-La Roche Ltd. - Segment focus •74.Fresenius SE & Co. KGaA - Overview •75.Fresenius SE & Co. KGaA - Business segments •76.Fresenius SE & Co. KGaA - Key offerings •77.Fresenius SE & Co. KGaA - Key customers •78.Fresenius SE & Co. KGaA - Segment focus •79.GlaxoSmithKline Plc - Overview •80.GlaxoSmithKline Plc - Business segments •81.GlaxoSmithKline Plc - Key offerings •82.GlaxoSmithKline Plc - Key customers •83.GlaxoSmithKline Plc - Segment focus •84.Merck & Co. Inc. - Overview •85.Merck & Co. Inc. - Product and service •86.Merck & Co. Inc. - Key offerings •87.Merck & Co. Inc. - Key customers •88.Merck & Co. Inc. - Segment focus •89.Novartis AG - Overview •90.Novartis AG - Business segments •91.Novartis AG - Key offerings •92.Novartis AG - Key customers •93.Novartis AG - Segment focus •94.Pfizer Inc. - Overview •95.Pfizer Inc. - Business segments •96.Pfizer Inc. - Key offerings •97.Pfizer Inc. - Key customers •98.Pfizer Inc. - Segment focus •99.Currency conversion rates for US$ •100.Research Methodology •101.Validation techniques employed for market sizing •102.Information sources •103.List of abbreviations

Amgen Inc., Biocon Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc.